Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan
· Delayed Price · Currency is TWD 127.00
+1.00 (0.79%)
Apr 2, 2025, 10:13 AM CST
Syngen Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 240.21 | 274.83 | 321.24 | 237.77 | 215.55 | Upgrade
|
| Depreciation & Amortization | 114.41 | 99.29 | 86.31 | 81.27 | 76.07 | Upgrade
|
| Other Amortization | 0.27 | 0.18 | 0.19 | 0.13 | 0.6 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.15 | 0.28 | 0.21 | 0.63 | 0.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 1.81 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.49 | -0.02 | -0.21 | -0.98 | 0.35 | Upgrade
|
| Loss (Gain) on Equity Investments | 5.32 | -36.08 | -26.64 | -14.81 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 6.92 | -8.58 | 17.82 | 0.33 | -1.77 | Upgrade
|
| Other Operating Activities | -5.37 | 12.24 | 36.67 | 33.37 | -2.13 | Upgrade
|
| Change in Accounts Receivable | -22.29 | 90.02 | -101.12 | -13.1 | -51.46 | Upgrade
|
| Change in Inventory | -1.19 | 1.98 | -98.11 | -41.33 | -51.5 | Upgrade
|
| Change in Accounts Payable | 25.8 | 20.49 | -62.12 | 57.78 | 12.1 | Upgrade
|
| Change in Unearned Revenue | 4.8 | 13.31 | 0.18 | 4.58 | -0.66 | Upgrade
|
| Change in Other Net Operating Assets | -21.48 | -52.82 | 103.07 | -10.94 | 22.84 | Upgrade
|
| Operating Cash Flow | 348.04 | 415.13 | 277.48 | 336.5 | 220.2 | Upgrade
|
| Operating Cash Flow Growth | -16.16% | 49.60% | -17.54% | 52.81% | -13.73% | Upgrade
|
| Capital Expenditures | -60.21 | -91.9 | -584.27 | -61.67 | -272.75 | Upgrade
|
| Sale (Purchase) of Intangibles | -4.13 | -1.91 | -0.44 | - | -0 | Upgrade
|
| Investment in Securities | -20 | - | - | -273.84 | - | Upgrade
|
| Other Investing Activities | -0.19 | 0.12 | -0.33 | -0.57 | 0.69 | Upgrade
|
| Investing Cash Flow | -84.53 | -93.68 | -585.05 | -336.08 | -272.06 | Upgrade
|
| Short-Term Debt Issued | 250 | 280 | 660 | 50 | 235 | Upgrade
|
| Long-Term Debt Issued | - | 106.49 | 132 | 50 | - | Upgrade
|
| Total Debt Issued | 250 | 386.49 | 792 | 100 | 235 | Upgrade
|
| Short-Term Debt Repaid | -330 | -430 | -430 | -100 | -185 | Upgrade
|
| Long-Term Debt Repaid | -73.63 | -21.67 | -14.95 | -14.02 | -12.67 | Upgrade
|
| Total Debt Repaid | -403.63 | -451.67 | -444.95 | -114.02 | -197.67 | Upgrade
|
| Net Debt Issued (Repaid) | -153.63 | -65.17 | 347.06 | -14.02 | 37.33 | Upgrade
|
| Common Dividends Paid | -135.5 | -135.5 | -108.4 | -94.85 | -81.3 | Upgrade
|
| Other Financing Activities | 0.05 | 0.14 | 0.1 | - | -0.02 | Upgrade
|
| Financing Cash Flow | -289.09 | -200.54 | 238.75 | -108.88 | -43.99 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.62 | -0.08 | 0.06 | -0.16 | -0.12 | Upgrade
|
| Net Cash Flow | -24.96 | 120.84 | -68.75 | -108.62 | -95.98 | Upgrade
|
| Free Cash Flow | 287.83 | 323.23 | -306.79 | 274.83 | -52.55 | Upgrade
|
| Free Cash Flow Growth | -10.95% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 14.29% | 17.59% | -15.89% | 18.68% | -4.01% | Upgrade
|
| Free Cash Flow Per Share | 10.61 | 11.91 | -11.31 | 10.13 | -1.94 | Upgrade
|
| Cash Interest Paid | 9.35 | 8.84 | 4.89 | 3.2 | 2.46 | Upgrade
|
| Cash Income Tax Paid | 86.68 | 75.3 | 60.15 | 28.87 | 55.18 | Upgrade
|
| Levered Free Cash Flow | 200.8 | 248.25 | -368.73 | 240.8 | -108.78 | Upgrade
|
| Unlevered Free Cash Flow | 206.6 | 253.78 | -365.56 | 242.8 | -107.24 | Upgrade
|
| Change in Net Working Capital | 33.31 | -58.82 | 93.83 | -47.15 | 73.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.